模拟多阶段疾病进展,并通过一种新的协作学习方法识别遗传风险因素
Duo Xi1, Minjianan Zhang1, Muheng Shang1
1School of Automation, Northwestern Polytechnical University, Xi'an 710072, China.
Bioinformatics (Oxford, England)
|December 10, 2024
概括
这项研究引入了MSColoR,一种新的方法,可以联合分阶段阿尔茨海默病 (AD) 的进展,并确定遗传风险因素. 这种方法提高了在诊断阿尔茨海默病和理解其遗传基础的准确性.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 计算生物学 计算生物学
背景情况:
- 阿尔茨海默病 (AD) 的进展是渐进的,需要分阶段进行诊断和治疗.
- 确定影响AD病变的遗传因素至关重要.
- 目前的方法通常会单独处理疾病分期和遗传变异识别.
研究的目的:
- 开发一种新的计算方法,共同模拟阿尔茨海默病的进展,并确定遗传风险因素.
- 解决疾病分期和遗传变异识别单独分析的局限性.
主要方法:
- 提出了一种稀疏的多阶段多任务混合效应协作纵向回归方法 (MSColoR).
- 通过使用纵向神经成像数据,MSColoR将疾病进展作为一个多阶段过程共同建模.
- 关联的适应性疾病轨迹与每个阶段的遗传变异,利用全基因组关联研究总结统计数据.
主要成果:
- MSColoR减少了纵向脑成像遗传学研究中的建模错误.
- 该方法可以更准确地识别与阿尔茨海默病进展相关的显著遗传变异.
- 使用合成和真实纵向神经成像和遗传数据进行评估,优于现有的纵向方法.
结论:
- MSColoR提供了一种强大的计算技术,用于分析阿尔茨海默病研究中的纵向脑成像遗传数据.
- 联合建模方法提高了对AD病原和遗传影响的理解.
- 公开可用的代码有助于进一步的研究和应用.
相关概念视频
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Genome-wide Association Studies-GWAS
12.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.4K
Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328


